Author: MIL-OSI Publisher

Source: World Health Organization (WHO)

Gavi, the Vaccine Alliance, UNICEF and WHO raise alarm over falling vaccine coverage and eroding trust, with measles cases at their highest since 2020

Manila/Bangkok/Geneva, 28 May 2025 – Across East Asia and the Pacific, vaccine-preventable diseases are making a dangerous comeback, with measles at the forefront of this resurgence. In the first months of 2025, countries like Cambodia, Mongolia, the Philippines, and Viet Nam have reported a sharp rise in measles cases compared with the same period last year, signalling that far too many children are missing out on life-saving vaccines.

Measles is among the most infectious diseases in the world, with the potential to cause severe illness and death, especially in children. Since the beginning of 2025, Viet Nam has recorded 81,691 suspected measles cases in 63 provinces and cities. As of 21 May, Mongolia had confirmed 2,682 measles cases. Cambodia reported 2,150 cases of measles between January and April 2025. The Philippines reported 2,068 cases from 1 January to 10 May 2025. Measles cases across the region are now at their highest level since 2020, according to data from the World Health Organization (WHO).

“The alarming rise in measles cases is a wake-up call,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “It highlights the vulnerable children who are being left behind — those who haven’t received even a single dose of vaccine, living in underserved communities, missed by routine immunization and vaccination campaigns. This underscores the critical importance of ensuring every child is immunized to protect their health and that of our communities.”

Meanwhile, the confirmation of a poliovirus outbreak in Papua New Guinea has triggered a national public health emergency response. The risk of continued transmission within the country remains high, with potential implications beyond its borders. Although Papua New Guinea was declared polio-free 25 years ago, persistently low routine immunization coverage has left many children vulnerable.

Vaccine-preventable diseases remain a significant threat to children’s health. Measles can cause serious complications including pneumonia, brain damage and lifelong disability. Polio can lead to irreversible paralysis. The youngest children, especially those living in poverty, conflict zones, remote areas, or without access to basic health care, are most at risk and least likely to recover.

“We’re not just seeing a spike in disease, we’re seeing a signal that the systems meant to protect children are faltering,” said June Kunugi, UNICEF Regional Director for East Asia and the Pacific. “Measles and polio are highly infectious, and children are paying the price for gaps in coverage, delayed care, and misinformation. No child should suffer or die from a disease we know how to prevent.”

The resurgence of vaccine-preventable diseases in East Asia and the Pacific reflects deeper, systemic failures. Immunization systems weakened by the COVID-19 pandemic remain under-resourced. Across the WHO Western Pacific Region, an estimated 3.2 million children did not receive a single dose of vaccine between 2020 and 2023. Many more children remain under-vaccinated, and even countries with previously strong systems are now grappling with immunity gaps. These setbacks have left millions of children vulnerable to diseases that should already be under control or eliminated. Additionally, rising vaccine hesitancy – driven by misinformation, disinformation, and distrust – is further eroding the confidence families need to protect their children.

“We are very concerned about the rising cases of measles in the region,” said Nadia Lasri, Senior Country Manager and Coordinator of Gavi, the Vaccine Alliance, in the Western Pacific Region. “Gavi is actively supporting response efforts in the region, including funding emergency vaccination campaigns, strengthening surveillance systems, and providing technical assistance to national immunization programmes. We are working with partners to bolster routine immunization systems and ensure children in hard-to-reach and cross-border areas are not left behind. The spike in cases underscores the urgent need for a coordinated regional response to stop transmission and protect millions of children.”

The cost of inaction is high: outbreaks demand emergency campaigns and intensive responses that are far more expensive than maintaining well-functioning, reliable routine immunization systems.

The tools to stop these diseases already exist: safe, effective, and affordable vaccines; early warning systems; and health workers with the skills and dedication to deliver them. UNICEF and WHO are calling for a shift from crisis response to prevention. That means:

• Reach every child with routine immunization and catch-up campaigns to close immunity gaps.
• Track risks and respond early with strong surveillance, laboratory capacity, and rapid outbreak response.
• Improve diagnosis and care with clear treatment protocols and infection control in health facilities.
• Build public trust by engaging communities, addressing concerns, and countering misinformation.
• Share timely information across countries to stay ahead of outbreaks.
• Ensure immunization programmes are adequately and sustainably resourced.

Critically, this work dep

Source: Equinor

28 MAY 2025 – On Tuesday May 27, 2025 Equinor ASA, guaranteed by Equinor Energy AS, executed the following debt capital market transactions:

Issue of USD 550 million 4.25% Notes due June 2, 2028
Issue of USD 400 million 4.50% Notes due September 3, 2030
Issue of USD 800 million 5.125% Notes due June 3, 2035

The net proceeds from the issue of the Notes will be used for general corporate purposes, which may include the repayment or purchase of existing debt or other purposes described in the prospectus supplement for the issue of Notes. The transaction will increase the financial flexibility of the company.

The offering is scheduled to close on June 3, 2025, subject to the satisfaction of customary conditions.

Any public offering in the United States is being made solely by means of a prospectus supplement to the prospectus included in the Registration Statement filed by Equinor ASA and Equinor Energy AS, and previously declared effective.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities of Equinor ASA nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The offering is being made pursuant to an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (“SEC”). The offering is being made only by means of a prospectus and related prospectus supplement. The prospectus and related preliminary prospectus supplement may be obtained by visiting the SEC's website at www.sec.gov. Alternatively, you may request these documents by calling (1) Barclays Capital Inc. at 1-888-603-5847, (2) BofA Securities, Inc. at 1-800-294-1322, (3) Deutsche Bank Securities Inc. at 1-800-503-4611, (4) Goldman Sachs & Co. LLC at 1-866-471-2526, or (5) J.P. Morgan Securities LLC at 1-212-834-4533.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act